Medical Condition

psoriatic arthritis

Total Trials

9

Recruiting Now

9

Trial Phases

Phase 2, Phase 3, Phase 4

ClinicalMetric tracks all active clinical trials for psoriatic arthritis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — psoriatic arthritis Clinical Trials

How many clinical trials are currently recruiting for psoriatic arthritis?

ClinicalMetric currently tracks 9 actively recruiting clinical trials for psoriatic arthritis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for psoriatic arthritis?

psoriatic arthritis research spans Phase 2 (3 trials), Phase 3 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a psoriatic arthritis clinical trial?

Eligibility criteria for psoriatic arthritis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 2

Phase 3

Phase 4

Enrollment

200 pts

Location

United States, Puert...

Sponsor

Eli Lilly and Company

View Trial →

NCT07486960 Phase 2

Recruiting

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology

psoriatic arthritis

Frequently Asked Questions — psoriatic arthritis Clinical Trials

Recruiting Clinical Trials

Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis

Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients

Evolution and Treatments of Chronic Inflammatory Systemic Diseases

A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)

HIPPOCRATES Prospective Observational Study

Immune-Competent Cell Manifestations in Psoriatic Arthritis Achilles Tendons